|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013018,
umls-concept:C0020456,
umls-concept:C0026809,
umls-concept:C0030274,
umls-concept:C0035015,
umls-concept:C0205369,
umls-concept:C0450127,
umls-concept:C0521457,
umls-concept:C0522536,
umls-concept:C1548437,
umls-concept:C1708528,
umls-concept:C1879316,
umls-concept:C1882923,
umls-concept:C2699427
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-3-18
|
|
pubmed:abstractText |
Fetal pancreas has been considered as an alternative donor source for islet transplantation since it has potent capacity for beta cell differentiation and proliferation. However, prevention of fetal pancreatic allograft rejection can be hardly achieved compared with adult islet allografts.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1536-4828
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
146-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15028946-Animals,
pubmed-meshheading:15028946-Blood Glucose,
pubmed-meshheading:15028946-Combined Modality Therapy,
pubmed-meshheading:15028946-Diabetes Mellitus, Experimental,
pubmed-meshheading:15028946-Fetal Tissue Transplantation,
pubmed-meshheading:15028946-Glucose Tolerance Test,
pubmed-meshheading:15028946-Graft Rejection,
pubmed-meshheading:15028946-Immunoconjugates,
pubmed-meshheading:15028946-Mice,
pubmed-meshheading:15028946-Pancreas Transplantation
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Amelioration of hyperglycemia in streptozotocin-induced diabetic mice with fetal pancreatic allografts: prevention of rejection by donor specific transfusion in conjunction with CTLA4Ig.
|
|
pubmed:affiliation |
Departments of Surgery I, Fukuoka University School of Medicine, Fukuoka 814-0180, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
